Pinned
BREAKING: FDA DATA REANALYSIS SENT TO SECRETARY KENNEDY FINDS MODERNA’S mRNA FLU SHOT APPROVAL SHOULD BE IMMEDIATELY WITHDRAWN
We directly reanalyzed the FDA’s own data used to approve mFLUSIVA and found an EXTREME risk-benefit profile that is impossible to justify.
To prevent
Plans are now underway to have the FDA withdraw its disastrous mRNA flu shot approval.
They will not be able to defend the damning data about to drop.
Stay tuned.



